News

The data assess the extended efficacy of the treatment for up to 4 years.

The device is now available at 2 US clinics, with training and installation currently underway at several other locations.

The device is currently under clinical trial investigation as an adjunct treatment to standard of care therapy for experiential negative symptoms of schizophrenia.

New study results show evenamide as an add-on to antipsychotics for treatment-resistant schizophrenia significantly reduced disease severity.

"Together we will win..."

A psychiatrist reflects on a new year and anticipatory growth.

Will this medication make me gain weight? Researchers analyzed response to antidepressant treatment as a predictor of incident metabolic syndrome in a cohort of patients with depression.

Here’s to being curious in 2024!

Here are some updates from the world of psychiatry throughout the month of December.

What is new in research on seasonal affective disorder?

Psychiatric Times chats with new Mood Disorders Section Editor Gus Alva, MD, about his new role, his interest in mood disorders, and his love of psychiatry.

The experts weighed in on a wide variety of psychiatric issues for the December 2023 issue of Psychiatric Times.

A medical student's award-winning piece on her battles with an eating disorder.

OABD is a significant concern among older adults, characterized by unique presentations and comorbidities. Here's what you need to know.

Clinicians must feel knowledgeable and masterful in incorporating lifestyle and integrative therapies targeting nutrition, stress reduction, normalization of sleep, aerobic and mindful exercise, and meaningful activities that add joy and life to years, and not just years to life.

Here are highlights from some of the year’s top features in Psychiatric Times from throughout 2023.

Review the uses and forms of transcranial magnetic stimulation.

Captagon tablets: how are they impacting the current state of world affairs?

Although psychiatric disorders are common among older adults, many of these individuals do not get the treatment they need. The Psychiatric Times Special Report on Geriatric Psychiatry discusses how we can improve outcomes for this patient population.

Reviewing a year of CMEs in Psychiatric Times®

On Christmas, a psychiatrist shares his emboldening reflections...

Here are some highlights from Frank A. Clark, MD’s, Poetry for Inclusion from throughout 2023, as seen in Psychiatric Times.

From new guidelines for the utilization of artificial intelligence in health care to the efficacy of fish oil as a replacement for antidepressants, here are highlights from the week in Psychiatric Times.

What is new in research on schizophrenia?

In this CME, learn more about the pathophysiology of HIV-associated neurocognitive disorder and to review the research and various tools used to aid in the diagnosis.

One doctor shares his story of becoming a community psychiatrist.

Did you miss the 2023 Annual Psychiatric Times World CME Conference? Don't worry, we've got you covered.

Here's how the Jewish stereotype of the hooked nose represents a greater problem: the resurgence of anti-Semitism.

Initial data from phase 2 safety profile for psilocybin in the treatment of PTSD indicates the treatment is well-tolerated.

"As I continue my medical sojourn, I am reminded that the world of health care is as diverse as the patients it serves."